Aims & Scope
Clinical Immunology, Endocrine & Metabolic Drugs publishes original research, expert reviews, drug clinical trials and thematic issues in all core areas of translational and clinical immunology, endocrine & metabolic drug research.
The journal publishes pre-clinical and clinical studies on the development of new immunology, endocrine & metabolic agents. Clinical studies of new reported immunology, endocrine & metabolic drugs include Phase 1 - IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinicians, toxicologists, medicinal chemists, and pharmacologists.